secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001628280-22-011723
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q1 revenue up 22.6% to $417.6M; raises FY22 guidance
-------------------------------------------------------------

- Net income $41.8M ($3.59 diluted EPS) vs $41.1M ($3.46) YoY.
- Active OPTA VIA coaches grew 21.7% to 63,900; avg revenue per coach up 1.3% to $6,536.
- FY22 revenue guidance raised to $1.78-1.84B (from $1.72-1.79B); EPS to $14.60-16.05.
- Quarterly dividend increased 15.5% to $1.64/share; $10M share repurchase in Q1.
- No interest-bearing debt; cash & securities $122.1M at March 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828022011723/0001628280-22-011723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828022011723/med-20220502.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-011723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer